Showing results (141-150 of 219) with videos related to

Sort By:
Pageof 22
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 28, 2022
Innovations in the prevention and treatment of postpartum hemorrhage: Analysis of a novel medicines development pipeline databaseAnnie R A McDougall, Maya Goldstein, Andrew Tuttle, et al.
Bone Marrow Transplantation|October 12, 1999
Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvementI Tezcan, O Sanal, F Ersoy, et al.
Health Research Policy and Systems|April 22, 2021
Regulatory standards and processes for over-the-counter availability of hormonal contraception and drugs for medical abortion in five countries in the Eastern Mediterranean RegionAnne Ammerdorffer, Mark Laws, Arinze Awiligwe, et al.
The Lancet. Global Health|June 14, 2024
The drug drought in maternal health: an ongoing predicamentAnne Ammerdorffer, Annie R A McDougall, Andrew Tuttle, et al.
BMC Medicine|November 4, 2022
Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profilesAnnie R A McDougall, Roxanne Hastie, Maya Goldstein, et al.
The Lancet. Global Health|August 9, 2014
Global causes of maternal death: a WHO systematic analysisLale Say, Doris Chou, Alison Gemmill, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 3, 2025
Polyphenols for the Prevention or Management of Preeclampsia: A Systematic Review and Meta-AnalysisPhi-Yen Nguyen, Ben Sanderson, Maureen Makama, et al.
Reproductive Health|May 27, 2015
WHO Better Outcomes in Labour Difficulty (BOLD) project: innovating to improve quality of care around the time of childbirthOlufemi T Oladapo, João Paulo Souza, Meghan A Bohren, et al.
European Journal of Clinical Investigation|March 19, 2009
Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous diseaseM Y Köker, K van Leeuwen, M de Boer, et al.
The Lancet. Global Health|December 20, 2024
Effectiveness and acceptability of a 24-h interval versus a 48-h interval between mifepristone intake and misoprostol administration for in-hospital abortion at 9-20 gestational weeks: an international, open-label, randomised, controlled, non-inferiority trialMargit Endler, Unnop Jaisamrarn, Suneeta Mittal, et al.
Pageof 22